Clinical trials
Active, not recruiting Phase 3 Coronary Artery Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 8 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 2 |
| Eli Lilly and Company | 1 |
| Guy's and St Thomas' NHS Foundation Trust | 1 |
| MedTrace Pharma A/S | 1 |
| NewAmsterdam Pharma | 1 |
| Suleyman Demirel University | 1 |
| iVascular S.L.U. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Coronary Artery Disease | 8 |
| Cardiovascular Diseases | 2 |
| Hyperlipidemias | 2 |
| Plaque, Atherosclerotic | 2 |
| Atherosclerosis | 1 |
| Cerebrovascular Disorders | 1 |
| Coronary Stenosis | 1 |
| Death | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| Dyslipidemias | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.